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Background: Whether acupuncture is effective for patients with functional constipation is still unclear. Therefore,
we report the protocol of a randomized controlled trial of using acupuncture to treat functional constipation.
Design: A randomized, controlled, four-arm design, large-scale trial is currently undergoing in China. Seven
hundred participants are randomly assigned to three acupuncture treatment groups and Mosapride Citrate control
group in a 1:1:1:1 ratio. Participants in acupuncture groups receive 16 sessions of acupuncture treatment, and are
followed up for a period of 9 weeks after randomization. The acupuncture groups are: (1) Back-Shu and Front-Mu
acupoints of Large Intestine meridians (Shu-Mu points group); (2) He-Sea and Lower He-Sea acupoints of Large
Intestine meridians (He points group); (3) Combining used Back-Shu, Front-Mu, He-Sea, and Lower He-Sea acupoints
of Large Intestine meridians (Shu-Mu-He points group). The control group is Mosapride Citrate group. The primary
outcome is frequency of defecation per week at the fourth week after randomization. The secondary outcomes
include Bristol stool scale, the extent of difficulty during defecating, MOS 36-item Short Form health survey (SF-36),
Self-Rating Anxiety Scale (SAS), and Self-rating Depression Scale (SDS). The first two of second outcomes are
measured 1 week before randomization and 2, 4, and 8 weeks after randomization. Other second outcomes are
measured 1 week before randomization and 2 and 4 weeks after randomization, but SF-36 is measured at
randomization and 4 weeks after randomization.
Discussion: The result of this trial (which will be available in 2012) will confirm whether acupuncture is effective to
treat functional constipation and whether traditional acupuncture theories play an important role in it.
Trials registration: Clinical Trials.gov NCT01411501
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Functional constipation is a common disease, both in adults
and in children. The prevalence in children ranges from
0.7% to 29.6%. In adults, functional constipation affects
between 0.7% and 79% of the general population [1]. The
prevalence is higher in females, older individuals, those of
lower socioeconomic status, and those with a lower educa-
tional level [2,3]. As a common and well-recognized public
health problem, functional constipation influences patient* Correspondence: zhubing@mail.cintcm.ac.cn; zhishunliu@yeah.net
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reproduction in any medium, provided the orquality of life and consumes many healthcare resources
[4,5].
Several therapies (such as lifestyle changes, osmotic
agents, bulking agents, and so on) [6,7] have been used in
clinical practice, which is believed to be helpful in relieving
symptoms. Nonetheless, many of these therapies were not
proven to be effective for the condition, or were difficult to
tolerate because of adverse events [8-10].
Because of the unclear etiology and pathogenesis, the
therapeutic options are relatively limited. As a result, com-
plementary or alternative therapies, such as acupuncture,
are attractive to both patients and practitioners. China has
a long history of managing gastrointestinal symptoms
through acupuncture, including diarrhea, constipation
and gastroenteritis [11]. Results of several randomizedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an effective treatment for functional constipation, by im-
proving frequency and time of defecation, and the
patient’s quality of life [12-14]. However, convincing evi-
dence for the effectiveness of treating functional constipa-
tion with acupuncture is still inadequate, due to the poor
quality of current studies. Therefore, we designed a multi-
center randomized controlled trial to address these pro-
blems and hopefully provide a more conclusive answer to
the questions.
In this trial, we first aim at investigating whether acu-
puncture is effective in treating functional constipation
through a comparison with Mosapride Citrate control.
Second, we will attempt to determine whether different
acupuncture points are the same in managing this condi-
tion. The work reported in this article is financed by the
National Basic Research Program (973 Program) in China,




This is a randomized controlled, four-arm, large-scale
trial comparing three acupuncture groups (using differ-
ent acupuncture points) with Mosapride Citrate control
group (Figures 1 and 2). Seven hundred participants will
be included from the following eight hospitals: Guang’an-
Men Hospital of China Academy of Chinese Medical
Sciences; First Affiliated Hospital of Chengdu University
of Traditional Chinese Medicine (TCM); Affiliated Hos-
pital of Anhui College of TCM; Affiliated Hospital of
Changchun University of TCM; Affiliated Hospital of
Guangzhou University of TCM; Affiliated Hospital of
Hunan University of TCM; Affiliated Hospital of Shan-
dong University of TCM; and Affiliated Hospital of Shanxi
College of TCM. These participants will be randomly
assigned to four groups (three acupuncture groups and
Mosapride Citrate control group) through central
randomization in a 1:1:1:1 ratio. The central randomization
system will be used and performed by the Clinical Evalu-
ation Center at the China Academy of Chinese Medical
Sciences in Beijing. A random number and group assign-
ment will be immediately received by telephone, mobile
phone, or website sent from the Clinical Evaluation Center.
Participants will receive 16 sessions of acupuncture
treatment over 4 weeks, with a treatment frequency of
five times a week in the first 2 weeks and three times a
week in the last 2 weeks. Each session will last 30 min.
The follow-up period lasts 4 weeks (5 to 8 weeks after
randomization). Participants will be asked to fill in consti-
pation diaries from 1 week before randomization to 9 weeks
after randomization. All outcomes are assessed at baseline
and 2, 4, and 8 weeks after randomization according to the
diaries.The total research period within this study is 9 weeks for
each patient. All patients are asked to record constipation
diaries for 1 week before randomization (baseline phase). If
they are eligible for this trial, they will be asked to finish
diaries from 0 to 8 weeks after randomization.
This trial protocol has been approved by local institu-
tional review boards and ethics committees (April 2011),
and follows the principles of the Declaration of Helsinki
(Version Edinburgh 2000). Before randomization all
patients will be requested to sign the written informed
consent, meanwhile they will be given enough time to
decide whether they are willing to participate this trial,
or they choose other treatment options.
Patients
Study population
This study focuses on patients with functional constipa-
tion, containing a sample size of 700 participants. There
are many potential factors leading to constipation, such
as food, drugs, and so on. To ensure the precision of
results of this trial, we developed the following eligible
criteria.
Inclusion criteria
Participants will be included if they fulfilled the following
conditions: diagnosed with functional constipation accord-
ing to the criteria of the Rome III [15]; aged between 18
and 75 years old; no use of gastrointestinal drugs 1 week
before randomization; provided a signed written consent
form.
Exclusion criteria
Patients with any of the following conditions will be
excluded: constipation caused by other disorders (for ex-
ample, irritable bowel syndrome, post-surgery constipa-
tion, and so on); psychosis (since acupuncture is an
invasive procedure and needs a treatment duration of
30 min, to ensure safety of patients with psychosis, we
do not plan to include them); pregnant women or
women in lactation (it is still unclear whether acupunc-
ture will lead to abortion or other side effects); bleeding
disorders (the acupuncture procedure involves penetra-
tion of the skin, therefore we will exclude participants
with thrombocytopenia, and so on); serious illnesses of
the heart, liver, or kidney, or other severe diseases (there
may be risks that acupuncture induces stress action and
thus harms patients with serious illness).
Recruitment procedures
Two strategies will be used to recruit participants with
functional constipation. The first is to recruit participants
in outpatient clinics from the eight hospitals. The chief phy-
sicians of gastroenterology and colorectal department in
each hospital were invited to attend a discussion of how to
Figure 1 Trial flow chart.
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departments to help screen participants. Moreover, posters
of this trial were shown outside the clinics to attract pos-
sible candidates. Second, we will post advertisements
through TV broadcasts, newspapers, and so on. In these
advertisements, we will briefly introduce the population we
want to include, and mention the free acupuncture treat-
ments for participants who are eligible.
Interventions and comparison
Rationale for acupuncture protocol
The acupuncture protocol in this trial was formed in
two steps: first, we screen for a range of acupuncture
points and stimulation methods through a systematic re-
view of records of ancient books and acupuncture text-
books, as well as results of published articles; second,
meetings were held to further screen for a standardized
acupuncture protocol and reach consensus among acu-
puncture experts in China. Based on the theory ofacupuncture and TCM, Back-Shu and Front-Mu points
(short for Shu-Mu points) are the classic combination
for the treatment of internal organ disease, which is
located in the abdomen or lower back of the body, so
Back-Shu and Front-Mu acupuncture points of Large In-
testine meridians are supposed to be the best points pre-
scription to treat Large Intestine disease. Additionally,
He-Sea and Lower He-Sea acupuncture points of Large
Intestine meridians are also positive points prescription,
which is situated in the upper or lower limbs of the
body, as stated: ’He points are the best points to treat in-
ternal organ’s disease’ in Nei Jing. In our hypothesis, the
combination of Shu-Mu points and He-sea points will
achieve better therapeutic outcomes, and all the acupunc-
ture groups will be non-inferior to Mosapride Citrate.
Therefore, groups in our trial are defined as: (1) Back-Shu
and Front-Mu acupoints of Large Intestine meridians
(Shu-Mu points) group; (2) He-Sea and Lower He-Sea
acupoints of Large Intestine meridians (He points) group;
Figure 2 Trial processes chart. SF-36, MOS item Short Form health survey; SAS, Self-Rating Anxiety Scale; SDS, Self-rating Depression Scale.
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Lower He-Sea acupoints of Large Intestine meridians
(Shu-Mu-He points) group; and (4) Mosapride Citrate
control group (Table 1).
Acupuncture groups
All acupuncture points are punctured by filiform nee-
dles. After being needled, the points will be punctured
again using auxiliary needles 2 mm lateral to the first
needle, and to a depth of 2 mm without manual stimula-
tion. G6805-1A electro-acupuncture apparatus (Shanghai
Huayi, made in Jiangsu, China) is used for electric stimula-
tion at every acupuncture point. Each acupuncture needle
and auxiliary needle of each point is connected with elec-
tricity by G6805-1A for 30 min, using continuous wave.The stimulation frequency is 20 Hz. The stimulation in-
tensity varies from 0.1 mA to 1.0 mA until the patients
feel comfortable.
Sterile, disposable Hwato needles are used in this trial,
which are made in Suzhou, China; they are 25 to 50 mm
in length and 0.3 mm in diameter. The auxiliary needles
are of the same brand with 13 mm in length and
0.16 mm in diameter. De qi sensation will be achieved in
the acupuncture groups, through lifting and thrusting
combined with twirling and rotating the needles. After
retaining the needles for 30 min, all needles are taken
out with clean cotton balls to avoid bleeding.
Every patient will receive 16 treatments in total over a
period of 4 weeks. Five times a week, with once a day
for 5 days continuously with a 2-day interval in the first
Table 1 Details of acupuncture protocol









Yes Both points are punctured bilaterally. Tianshu (ST25) is
punctured perpendicularly 1–1.5 cun. Dachangshu (BL25)
is punctured perpendicularly 0.8-1.2 cun
He-Sea and Lower He-Sea
acupoints of Large Intestine
meridians (He points group)
Quchi (LI11)
Shangjuxu (ST37)
Yes Both points are punctured bilaterally. Quchi (LI11) is
punctured perpendicularly 0.5-1 cun. Shangjuxu (ST37) is
punctured perpendicularly 1–2 cun
Combining used Back-Shu,
Front-Mu, He-Sea, and








Yes Stimulation is the same as above mentioned
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interval in the last 2 weeks.
Control group
Participants will be orally given Mosapride Citrate tablet
with a dose of 5 mg, three times a day for 4 weeks
continuously.
Outcome measurement
The primary outcome in this trial is the number of
times of defecation throughout the fourth week after
randomization. The primary outcome will be measured
at the other time points (2 and 8 weeks after
randomization) but as a secondary analysis. The second
outcomes include the following five items: shape and
properties of stool; intensity of defecating difficulty;
MOS item Short Form health survey (SF-36); Self-
Rating Anxiety Scale (SAS); and Self-rating Depression
Scale (SDS). The first two of second outcomes are mea-
sured in 1 week before randomization and 2, 4, and
8 weeks after randomization. Other second outcomes
are measured 1 week before randomization and 2 and
4 weeks after randomization, but SF-36 is measured
before randomization and 4 weeks after randomization.
All patients have to fill in constipation diaries 1 week
before randomization (baseline phase) and 2, 4, and
8 weeks after randomization.
All participants will receive routine tests of blood,
urine, and stool, and electrocardiogram (ECG), liver
function (ALT, AST), kidney function (BUN, Scr) before
randomization, in order to exclude patients who have
serious heart, liver, and kidney disease, or other severe
disease. Only routine tests of stool should be done twice
before randomization and after accomplishment of acu-
puncture treatment.
During the trial, all adverse events, including bleeding,
hematoma, fainting, serious pain, local infection, and so
on, are to be recorded during treatment and the follow-
up period. Serious adverse events should be reported tothe principal investigator immediately. All details will be
documented and treatment options for rescue should be
given at once. To guarantee the quality of the study, all
acupuncturists are required to attend special training
classes. The purpose of these training classes is for acu-
puncturists to understand all the details of this trial. The
special training classes have theoretical and practical les-
sons. For instance, they will be trained to use the central
randomization method, to fill in the case report form, to
find the correct points, to manipulate the needles, to
choose electro-acupuncture apparatus, and so on. After
attending all training classes and passing the special
training test, acupuncturists are qualified to perform this
trial. Additionally, to ensure the quality of this trial, the
clinical monitors will check the processes of the trial
and documenting the details of the processes once a
month in every hospital. Moreover, monitors named by
the principle investigator will check the accuracy and
validity of the original data from the clinical centers.
Patient drop-outs and their reasons, and patients’ com-
pliance will be recorded at the fourth week after
randomization.
Sample size calculation and statistical analysis
According to the previous literature [16], an improve-
ment of 2.6 times (standard deviation 2.4) for defecating
during 1 week with functional constipation by prucalo-
pride is reported, and a difference of 1.6 times between
groups is considered to be of clinical relevance [16]. In
this study, we anticipated an improvement of 4.0 times
by Shu-Mu points group, 3.8 times by He points group,
5.2 times by Shu-Mu-He points group, and 2.6 times by
Mosapride Citrate tablet group. A standard deviation of
6.0 is considered, to allow a relatively high heteroge-
neous variance in this population. Moreover, we mainly
focus on the comparison of Shu-Mu-He points group vs.
Mosapride Citrate tablet group. So the between-group
comparison will be done as: first, Shu-Mu-He points
group will be compared with Mosapride Citrate tablet
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of Shu-Mu-He points is considered to be better than the
other two acupuncture protocols; second, comparisons
among acupuncture groups will be performed also as ex-
ploratory analysis. So, we used GPower 3.1.3 [Franz Faul,
Universität Kiel, Germany], and input the four group
mean defecation rates as 4.0, 3.8, 5.2, and 2.6 per week,
with a common assumed standard deviation of 6.0, giv-
ing a calculated effect size of 0.15. With four groups of
equal size (175/group, 700 in total) this gives the study
90% power at a 5% level of significance to detect such an
overall effect size using a one-way ANOVA fixed effects
omnibus test, and assuming a 15% loss to follow-up. For
the pairwise comparison of primary interest (Shu-Mu-
He vs. mosapride citrate) the study has over 90% power
at a 1% level of significance (to make some adjustment
for multiple comparisons) to detect a mean difference of
2.6 (5.2 to 2.6) assuming the common standard deviation
of 6.0 defecations with 175 participants per group.
Statistical analysis will be performed by the Clinical
Evaluation Center of China Academy of Chinese Medical
Sciences in Beijing. The statistician is blinded from the
allocation of groups. SPSS13.0 and SAS9.0 statistical
software packages will be used to analyze the data.
Prior to all analyses, a detailed statistical analysis
protocol was developed. The intention-to-treat (ITT)
population was defined as the patients who are rando-
mized and received at least one treatment session. The
per-protocol (PP) population was defined as the patients
who completed the study and do not have major proto-
col violations. All analyses were based on the ITT popu-
lation and PP population. And the result of the ITT
analysis will be compared with that of the PP analysis to
check whether the results are consistent.
First of all, baseline characteristics will be analyzed by
descriptive statistics for each group. Then analysis is
done to make comparisons among the treatment groups
and control group. If a significant difference is found by
comparison of the treatment groups and the control
group, the next step is to make comparisons among
three acupuncture points treatment groups in effective-
ness. Multiple comparisons will be adjusted according to
Bonferroni correction method.
The repeated measures analysis will be used in the dif-
ferent time points assessment. The Kruskal-Wallis test
will be employed in the analysis of skewed distribution
data. Analysis of variance (ANOVA) is used for numer-
ical variables, and Chi-square test for categorical
variables.
There is one acupuncturist in each center to do all
three interventions, which probably introduces cluster-
ing effect in this trial. Therefore, we calculated the
intracluster correlation coefficient from the results of
this trial and report the coefficient [17].Discussions
The result of this trial is expected to provide convincing
evidence that acupuncture is effective for patients with
functional constipation. The trial is sponsored and finan-
cially supported by ’973 Program’ from the Ministry of
Science and Technology of China, which is the most im-
portant basic research program based on clinical prac-
tice. Functional constipation is one of the 43 common
diseases which the World Health Organization recom-
mended acupuncture treatment for. However, currently
there is not enough evidence for acupuncture based on
strict clinical trial of evidence-based medicine (EBM) be-
cause of the poor quality of current studies, for example,
small sample size, no description of methods for
randomization, no standardized acupuncture protocol
which may lead to performance bias, and so on. In this
trial, we used central randomization, multicenter design,
standardized acupuncture protocol, large sample size to
ensure power, and so on. Therefore we conduct a multi-
center randomized controlled large-scale trial to clarify
the efficacy of acupuncture for treating functional
constipation.
A major issue in planning the design of this trial is
whether sham acupuncture should be used. Since the
primary consideration of this trial is to clarify whether
acupuncture is effective or whether acupuncture helps
relieving symptoms of patients with functional constipa-
tion, we all agree that a pragmatic design is more suit-
able, which requires a positive drug as the control
group. There is some evidence that Mosapride is effect-
ive for improvement of lower tract mobility, and thus is
effective for management of constipation [18-20]. How-
ever, there is no proven drug clearly ahead of the rest.
We choose Mosapride as a positive drug control based
on: (1) it was reported to be superior to placebo for irrit-
able bowel syndrome (IBS) patients with constipation,
and it may have the potential to treat IBS patients with
constipation and/or functional constipation [21]; and (2)
a randomized controlled trial in China showed the same
result [22], which indicates Mosapride may be a better
option than other medication for Chinese population
with functional constipation. So we choose Mosapride
Citrate as a positive drug control. In this trial, we did
not include a placebo acupuncture control, because we
did not know whether acupuncture is effective for
patients with functional constipation. Thus, if acupunc-
ture is effective, then the next step would be to compare
acupuncture with sham acupuncture to clarify absolute
acupuncture treatment effect.
There are three different acupuncture groups in this
trial, which are all expected to be effective according to
traditional acupuncture theories. Combined use of Back-
Shu and Front-Mu (Shu-Mu points) are regarded as the
most commonly acupuncture prescription. In addition,
Li et al. Trials 2012, 13:104 Page 7 of 8
http://www.trialsjournal.com/content/13/1/104He-Sea and Lower He-Sea points of Large Intestine mer-
idians are also commonly used acupuncture prescription.
The prescription of Shu-Mu-He points is composed of
both Shu-Mu points (Shu-Mu points group, located at
abdomen and lower-back) and He points (He points
group, located at upper and lower limbs), which is
expected to be the best therapeutic effect. Comparison
of the three acupuncture groups will solve the question:
whether combined use of Shu-Mu-He points will lead to
better clinical outcome than using Shu-Mu or He points
alone, which may give insights to whether traditional
acupuncture theories work.
In this trial, we use 3:1 randomization design comparing
three different types of acupuncture to Mosapride Citrate,
but not to a sham acupuncture group or a placebo group.
Because this trial is to answer whether acupuncture is ef-
fective and safe, regarding Mosapride Citrate is an effective
drug for functional constipation, we compare acupuncture
with Mosapride Citrate (positive drug control). Further-
more, although all three acupuncture points are believed to
be effective for the condition, the combination of Shu-Mu-
He points (Shu-Mu-He points group) is better than the
other two (Shu-Mu points group and He points group), so
the other two groups could be considered to be control
groups (more powerful sham acupuncture groups than
non-acupoints control groups) for Shu-Mu-He points
group.
Before this trial, we ran a small sample randomized
controlled trial of acupuncture for patients with func-
tional constipation, with a follow-up period of 6 months
[23]. The results showed that acupuncture at Tianshu
(ST25) would increase the frequency of defecation after
acupuncture treatment and last for about 1 month, so
we choose to follow up participants for 4 weeks after
treatment. Moreover, to get more information of acu-
puncture effect on functional constipation, we set an as-
sessment period at 2 weeks after inclusion.
We focus on a specific population though this trial is a
pragmatic design. First, we exclude patients with constipa-
tion caused by other disorders, especially for constipation
caused by surgery and irritable bowel syndrome. Because
constipation after surgery may be caused by anesthesia,
pain medication, and so on, which acupuncture may not be
helpful in these conditions according to the previous inves-
tigation [18,23]. Second, we exclude functional constipation
patients accompanying other serious conditions, for ex-
ample, heart failure, kidney failure, and so on, to ensure
acupuncture would not do harm to these patients.
According to recommendations of a responder in clinical
trials for functional gastrointestinal disorders [24], self-
reported diaries will be used in this trial. The participants
will know whether they receive acupuncture or medication,
but will not know which type of acupuncture they have
received, therefore, participants in Mosapride group mightbias the outcome assessment. The primary outcome and
the secondary outcomes will be calculated from the diaries.
Considering that the frequency of defecation is the most
important concern of patients with functional constipation,
and that acupuncture may be of best effect at the end of
the treatment [25,26], we choose the number of times for
defecating during 1 week in the fourth week after
randomization [24].
Due to lack of clear evidence of effectiveness with acu-
puncture to treating functional constipation, our trial aims
to clarify this issue by means of a multicenter randomized
controlled large-scale trial.
In conclusion, the results of this trial are expected to
confirm whether acupuncture is effective in the manage-
ment of functional constipation and whether traditional
acupuncture theories play an important role in it.
Trial status
The first participants were included on August 17, 2011,
and this article was submitted on November 1, 2011. To
date, 340 participants have been recruited.
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